How does Immunocine’s cancer treatment work?
+
The Immunocine Treatment stimulates your body to destroy your specific cancer, with a breakthrough approach to Immunotherapy that is completely natural, targeted, and unique.
Our treatment starts with collecting both a sample of a patient’s tumor and their own Dendritic Cells. In the Immunocine Laboratory, our team educates these Dendritic Cells to recognize and initiate a comprehensive attack against the cancer cells. Our treatment is completely personalized to each patient and their specific cancer.
As these are your own cells and nothing foreign is introduced to your body, our treatment is actually natural and safe despite being incredibly effective. Our treatment paradigm revolves around your body’s natural ability to destroy the cancer cells if it knows what cells to attack specifically.
Our treatment starts with collecting both a sample of a patient’s tumor and their own Dendritic Cells. In the Immunocine Laboratory, our team educates these Dendritic Cells to recognize and initiate a comprehensive attack against the cancer cells. Our treatment is completely personalized to each patient and their specific cancer.
As these are your own cells and nothing foreign is introduced to your body, our treatment is actually natural and safe despite being incredibly effective. Our treatment paradigm revolves around your body’s natural ability to destroy the cancer cells if it knows what cells to attack specifically.
Why is your treatment so unique?
+
Immunocine certainly does not provide the only Immunotherapy based on Dendritic Cells. With that being said, Immunocine’s Treatment is the only Dendritic Cell Treatment to properly activate the Immune System, which leads to an aggressive attack against a patient’s cancer.
Even including other cancer treatments beyond Dendritic Cell Treatments, our treatment is the only treatment to stimulate a TH1 High Response against a patient’s cancer cells.
This is the same response generated during a viral infection and corresponds with the rapid activation of specific immune cells capable of destroying any targeted cell in the body. Our Team does this through a patented process that effectively "Double Loads" the Dendritic Cell, in a very similar manner to an invading virus.
In a viral response, your body’s primary defense is to destroy the virally infected cells before they infect other cells. Instead of targeting the virally infected cells in your body, our treatment enacts the same response but instead targets the cancer cells.
Other than the FDA Clinical Trials for Glioblastoma and Pancreatic Cancer, Immunocine is the only treatment center where you can receive this proprietary Dendritic Cell Therapy.
Even including other cancer treatments beyond Dendritic Cell Treatments, our treatment is the only treatment to stimulate a TH1 High Response against a patient’s cancer cells.
This is the same response generated during a viral infection and corresponds with the rapid activation of specific immune cells capable of destroying any targeted cell in the body. Our Team does this through a patented process that effectively "Double Loads" the Dendritic Cell, in a very similar manner to an invading virus.
In a viral response, your body’s primary defense is to destroy the virally infected cells before they infect other cells. Instead of targeting the virally infected cells in your body, our treatment enacts the same response but instead targets the cancer cells.
Other than the FDA Clinical Trials for Glioblastoma and Pancreatic Cancer, Immunocine is the only treatment center where you can receive this proprietary Dendritic Cell Therapy.
How is Immunocine different than other Dendritic Cell Treatments?
+
Dendritic Cell Loading Immunocine’s Treatment uses a patent-protected Double Loading technique to educate the patient’s Dendritic Cells with the patient’s unique cancer markers. In comparison, other Dendritic Cell Treatments only load a patient’s Dendritic Cells in a singular manner, either internally or externally.
Peer-reviewed research has proven time and time again that Double Loading is the only known way to fully activate a Th1 immune response, which is necessary to engage a patient’s Killer T cells to destroy the cancer cells. In comparison, single loading only generates a limited immune response.
Treatment Administration - Immunocine’s Treatment is one of the few treatments that use an Interventional Radiologist to administer the treatment via an ultrasound-guided injection. The Interventional Radiologist targets the injection as close as possible to the patient’s lymph node closest to their tumor.
This step is also essential to ensure the Dendritic Cells immediately start activating an immune response. Other Dendritic Cell Treatments rely on intramuscular injection or IV infusion will delay treatment onset and risk the Dendritic Cells not fully activating the Immune System.
Peer-reviewed research has proven time and time again that Double Loading is the only known way to fully activate a Th1 immune response, which is necessary to engage a patient’s Killer T cells to destroy the cancer cells. In comparison, single loading only generates a limited immune response.
Treatment Administration - Immunocine’s Treatment is one of the few treatments that use an Interventional Radiologist to administer the treatment via an ultrasound-guided injection. The Interventional Radiologist targets the injection as close as possible to the patient’s lymph node closest to their tumor.
This step is also essential to ensure the Dendritic Cells immediately start activating an immune response. Other Dendritic Cell Treatments rely on intramuscular injection or IV infusion will delay treatment onset and risk the Dendritic Cells not fully activating the Immune System.
Do you have any peer-reviewed research?
+
Absolutely. There are 17 unique, peer-reviewed publications specific to Immunocine’s protocol. This research started in 2006 and continues to this day through various groups within the Texas Medical Center.
We would be more than happy to share the specific publications with any patient or referring physician interested in learning more
We would be more than happy to share the specific publications with any patient or referring physician interested in learning more
How long is the treatment?
+
Spread over the course of six weeks, the Immunocine Dendritic Cell Treatment (IDCT) is a unique and comprehensive Immunotherapy solely focused on activating a natural and aggressive immune response against our patient's cancer.
While some patients choose to stay in Cancun for all six weeks, many patients split their stay into two trips. As there are extended periods of downtime to allow the Immune System to respond to the treatment, many patients will come to Cancun for two weeks to start the treatment and return for a two-week trip to complete the treatment.
While some patients choose to stay in Cancun for all six weeks, many patients split their stay into two trips. As there are extended periods of downtime to allow the Immune System to respond to the treatment, many patients will come to Cancun for two weeks to start the treatment and return for a two-week trip to complete the treatment.
What side effects should I expect during and after treatment?
+
For the Immunocine Treatment, patients will typically experience the effects of an immune response no different than when they are fighting a cold or the flu. This can include fatigue, fever, aches, swollen lymph nodes, and loss of appetite.
Patients with tumors in sensitive locations or in their bones may also feel a varying level of soreness at the tumor sites as a result of the immune response.
Fortunately, these symptoms will reduce over time and will disappear once the patient’s cancer has been eliminated. Furthermore, these symptoms are only the result of the Immune System attacking the patient’s cancer and are a positive sign that the treatment is working.
Patients with tumors in sensitive locations or in their bones may also feel a varying level of soreness at the tumor sites as a result of the immune response.
Fortunately, these symptoms will reduce over time and will disappear once the patient’s cancer has been eliminated. Furthermore, these symptoms are only the result of the Immune System attacking the patient’s cancer and are a positive sign that the treatment is working.
What is the cost of the treatment?
+
The entire cost of our treatment is $85,000, which includes everything related to the medical treatment and transportation for your treatments.
We know that this is a price that may not be accessible to many patients. Unfortunately, each treatment is personalized to every patient and takes over a week to develop in our cGMP laboratory. Without cutting any corners, our team has tried to make the treatment as affordable as possible.
We know that this is a price that may not be accessible to many patients. Unfortunately, each treatment is personalized to every patient and takes over a week to develop in our cGMP laboratory. Without cutting any corners, our team has tried to make the treatment as affordable as possible.
Does Immunocine provide treatment financing?
+
While Immunocine does not offer treatment financing directly, our team has partnered with two companies to work with prospective Immunocine patients. If you have any interest in pursuing these options, please let us know.
LightStream Medical Financing - LightStream guarantees the lowest interest rate on Medical Financing. You can choose to pay the loan back in 3 - 7 years with payments lower than $1,300 per month. Your approval does not require any collateral and can be determined in as little as 5 days.
Life Credit - Life Credit will allow you to borrow up to 50% against your life insurance. This allows you to keep your life insurance and any associated benefits.
LightStream Medical Financing - LightStream guarantees the lowest interest rate on Medical Financing. You can choose to pay the loan back in 3 - 7 years with payments lower than $1,300 per month. Your approval does not require any collateral and can be determined in as little as 5 days.
Life Credit - Life Credit will allow you to borrow up to 50% against your life insurance. This allows you to keep your life insurance and any associated benefits.